| OFFERING INFORMATION ON HIV/AIDS TREATMENT, PREVENTION, AND RESEARCH | | |
|
| News and Features | Updates to the Microsporidiosis Section of the Adult and Adolescent Opportunistic Infections Guidelines The Microsporidiosis section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV has been updated. The Panel provided an update on the various microsporidia that have been documented in human infections and the correct taxonomy for these organisms, including the relationship of the microsporidia to the cryptomycota. The therapeutics section has been updated to include information on the availability of fumagillin for the treatment of Enterocytozoon bieneusi infection, including contact information for obtaining this medication from Sanofi. In addition, data on the use of nitazoxanide for the treatment of microsporidiosis is discussed. The reference section has been updated to include the authoritative textbook Microsporidia: Pathogens of Opportunity.
AIDSinfo Updates Investigational HIV Drug Fact Sheets AIDSinfo recently updated several investigational HIV drug fact sheets. These drugs, microbicides, and vaccines are currently being studied in clinical trials and are not approved by the U.S. Food and Drug Administration for sale in the United States to treat or prevent HIV. The investigational drug fact sheets are available in two formats: a plain language version, which includes an overview of the drug and information on clinical trials studying the drug; and a health professional version, which includes detailed, scientific information about the drug, including information on the pharmacology of the drug and on adverse events of the drug identified in clinical trials. View the updated fact sheets: 3BNC117 Dapivirine Elsulfavirine Peginterferon Alfa-2b Tat Oyi Tenofovir-Based Microbicides UB-421 Visit infoSIDA to view the drug fact sheets in Spanish. |
| |
|
You are subscribed as newsletter@newslettercollector.com. Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit the GovDelivery Subscriber Help Center at https://insights.govdelivery.com/Communications/Subscriber_Help_Center.
This service is provided to you at no charge by AIDSinfo.
This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: AIDSinfo P.O. Box 4780Rockville, MD 20849-6303 | |